Allen A Lee1, Krishna Rao2, Julajak Limsrivilai3, Merritt Gillilland1, Benjamin Malamet4, Emily Briggs1, Vincent B Young2,5, Peter D R Higgins1. 1. Division of Gastroenterology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI. 2. Division of Infectious Diseases, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI. 3. Division of Gastroenterology, Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. 4. Oakland University William Beaumont School of Medicine, Rochester, MI. 5. Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor, MI.
Abstract
BACKGROUND: Ulcerative colitis (UC) carries an increased risk of primary and recurrent Clostridiodes difficile infection (rCDI), and CDI is associated with UC flares. We hypothesized that specific fecal microbial changes associate with UC flare and rCDI. METHODS: We conducted a prospective observational cohort study of 57 patients with UC and CDI, CDI only, and UC only. Stool samples were collected at baseline, at the end of antibiotic therapy, and after reconstitution for 16S rRNA sequencing. The primary outcomes were recurrent UC flare and rCDI. Logistic regression and Lasso models were constructed for analysis. RESULTS: There were 21 (45.7%) patients with rCDI, whereas 11 (34.4%) developed UC flare. Patients with rCDI demonstrated significant interindividual (P = 0.008) and intraindividual differences (P = 0.004) in community structure by Jensen-Shannon distance (JSD) compared with non-rCDI. Two cross-validated Lasso regression models predicted risk of rCDI: a baseline model with female gender, hospitalization for UC in the past year, increased Ruminococcaceae and Verrucomicrobia, and decreased Eubacteriaceae, Enterobacteriaceae, Lachnospiraceae, and Veillonellaceae (AuROC, 0.94); and a model 14 days after completion of antibiotics with female gender, increased Shannon diversity, Ruminococcaceae and Enterobacteriaceae, and decreased community richness and Faecalibacterium (AuROC, 0.9). Adding JSD between baseline and post-treatment samples to the latter model improved fit (AuROC, 0.94). A baseline model including UC hospitalization in the past year and increased Bacteroidetes was associated with increased risk for UC flare (AuROC, 0.88). CONCLUSION: Fecal microbial features at baseline and after therapy predict rCDI risk in patients with and without UC. These results may help risk stratify patients to guide management.
BACKGROUND: Ulcerative colitis (UC) carries an increased risk of primary and recurrent Clostridiodes difficile infection (rCDI), and CDI is associated with UC flares. We hypothesized that specific fecal microbial changes associate with UC flare and rCDI. METHODS: We conducted a prospective observational cohort study of 57 patients with UC and CDI, CDI only, and UC only. Stool samples were collected at baseline, at the end of antibiotic therapy, and after reconstitution for 16S rRNA sequencing. The primary outcomes were recurrent UC flare and rCDI. Logistic regression and Lasso models were constructed for analysis. RESULTS: There were 21 (45.7%) patients with rCDI, whereas 11 (34.4%) developed UC flare. Patients with rCDI demonstrated significant interindividual (P = 0.008) and intraindividual differences (P = 0.004) in community structure by Jensen-Shannon distance (JSD) compared with non-rCDI. Two cross-validated Lasso regression models predicted risk of rCDI: a baseline model with female gender, hospitalization for UC in the past year, increased Ruminococcaceae and Verrucomicrobia, and decreased Eubacteriaceae, Enterobacteriaceae, Lachnospiraceae, and Veillonellaceae (AuROC, 0.94); and a model 14 days after completion of antibiotics with female gender, increased Shannon diversity, Ruminococcaceae and Enterobacteriaceae, and decreased community richness and Faecalibacterium (AuROC, 0.9). Adding JSD between baseline and post-treatment samples to the latter model improved fit (AuROC, 0.94). A baseline model including UC hospitalization in the past year and increased Bacteroidetes was associated with increased risk for UC flare (AuROC, 0.88). CONCLUSION: Fecal microbial features at baseline and after therapy predict rCDI risk in patients with and without UC. These results may help risk stratify patients to guide management.
Authors: Derrick W Crook; A Sarah Walker; Yin Kean; Karl Weiss; Oliver A Cornely; Mark A Miller; Roberto Esposito; Thomas J Louie; Nicole E Stoesser; Bernadette C Young; Brian J Angus; Sherwood L Gorbach; Timothy E A Peto Journal: Clin Infect Dis Date: 2012-08 Impact factor: 9.079
Authors: Christian Milani; Andrea Ticinesi; Jacoline Gerritsen; Antonio Nouvenne; Gabriele Andrea Lugli; Leonardo Mancabelli; Francesca Turroni; Sabrina Duranti; Marta Mangifesta; Alice Viappiani; Chiara Ferrario; Marcello Maggio; Fulvio Lauretani; Willem De Vos; Douwe van Sinderen; Tiziana Meschi; Marco Ventura Journal: Sci Rep Date: 2016-05-11 Impact factor: 4.379
Authors: Hiroko Nagao-Kitamoto; Andrew B Shreiner; Merritt G Gillilland; Sho Kitamoto; Chiharu Ishii; Akiyoshi Hirayama; Peter Kuffa; Mohamad El-Zaatari; Helmut Grasberger; Anna M Seekatz; Peter D R Higgins; Vincent B Young; Shinji Fukuda; John Y Kao; Nobuhiko Kamada Journal: Cell Mol Gastroenterol Hepatol Date: 2016-03-03
Authors: Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan Journal: Genome Med Date: 2016-07-13 Impact factor: 11.117
Authors: Alyxandria M Schubert; Mary A M Rogers; Cathrin Ring; Jill Mogle; Joseph P Petrosino; Vincent B Young; David M Aronoff; Patrick D Schloss Journal: MBio Date: 2014-05-06 Impact factor: 7.867